By Doug Macron

The National Institutes of Health this month set aside nearly $400,000 to fund three research projects focused on microRNAs and the heart, including one issued to a company aiming to develop an miRNA antagonist to prevent cardiac ischemia.

One of the NIH grants was awarded to New Jersey-based Vasade Biosciences, which specializes in developing drugs for cardiovascular diseases, to support its work on an inhibitor of miR-199a.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.